buserelin has been researched along with Pelvic Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitawaki, J; Kusuki, I; Suganuma, I; Yamanaka, K | 1 |
| Bier, UW; Bühler, K; Kato, K; Regidor, M; Regidor, PA; Schindler, AE | 1 |
1 trial(s) available for buserelin and Pelvic Pain
| Article | Year |
|---|---|
Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2011 |
1 other study(ies) available for buserelin and Pelvic Pain
| Article | Year |
|---|---|
Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur), were evaluated in re
Topics: Adult; Buserelin; Endometriosis; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Incidence; Infertility, Female; Pelvic Pain; Pregnancy; Pregnancy Outcome; Receptors, LHRH; Recurrence; Surveys and Questionnaires; Time Factors; Treatment Outcome | 1997 |